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Norcantharidin (NCTD), a demethylated form of cantharidin, is now in used as a routine anticancer drug. 
However, the detailed mechanisms underlying this process are generally unclear. The aims of this study 
were to evaluate the apoptotic effects and molecular mechanisms of NCTD. MTT assay was used to 
determine the cell growth inhibitory rate. Flow cytometry were used to detect the apoptosis and the loss 
of mitochondrial membrane potential (m) induced by NCTD. Caspase detection kit were used to detect 
the activity of caspase-3 -9. Western-blot was used to detect the expression of Bcl-2, Bax and 
cytochrome C (cyt C). Our results indicated that, treatment of NCTD resulted in significant decrease in 
cell viability in a dose-and time-dependent manner. A dose-dependent apoptosis was also observed by 
flow cytometery analysis. Molecular mechanistic studies of apoptosis revealed that, NCTD treatment 
resulted in a significant loss of m, release of cyt C, enhanced expression of pro-apoptotic protein Bax 
and suppression of anti-apoptotic protein Bcl-2. These were followed by activation of caspases-9 and -3, 
subsequently leading to cell apoptosis. These results indicate that, NCTD induced cytotoxicity in HepG2 
cells by apoptosis, which is mediated through mitochondrial pathway. 
 





Hepatoma is one of the most common malignancies 
worldwide with an overall 5-year survival of less than 14%. 
Jemal et al. (2010) estimated 17,430 new cases for men 
and 6,690 new cases for women in 2010 with 3.3% of all 
cancer deaths for both sexes being attributable to 
hepatoma. However, the available treatment and surgical 
options have proven to be inadequate in controlling the 
mortality and morbidity associated with this disease. It is 
therefore, necessary to intensify our efforts to develop 
new therapeutic agents for its prevention and treatment. 
Many lines of evidence have shown that the Chinese 
medicine contains many chemical compounds with 
anticancer effects (Li et al., 2010; Mack et al., 1996).  
Thus, we tested whether the active ingredients of specific 
Chinese medicines have a therapeutic effect on human 
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Abbreviation: m; Mitochondria membrane potential Chinese 
analog of cantharidin purified from the dried body of the 
Chinese blister beetle, Mylabris, which is a traditional 
medicine long been used for treating malignant tumors 
(Wang, 1989). In comparison with cantharidin, the major 
bioactive compound in Mylabris, NCTD has the 
advantage of easy synthesis and reduced intrinsic toxicity, 
while retaining its anti-cancer activity (Kok et al., 2005). 
The anticancer mechanisms of NCTD have been illuminated 
by the evidence showing its anti-proliferation, pro- 
apoptotic and anti-migratory effects on many cancer cells 
(Peng et al., 2002; Chen et al., 2002; Sun et al., 2000; 
Hong et al., 2000). However, the signaling pathways 
governing apoptosis in human HepG2 cells remains 
unclear. 
This study was conducted to investigate NCTD induced 
toxicity in human HepG2 cells and the possible role of 
mitochondrial pathway in the toxic effects. Under 
experimental conditions, NCTD inhibited proliferation and 
induced apoptosis of HepG2 cells in a concen- 
tration-dependent manner. The results suggest that, 
NCTD -induced apoptosis in HepG2 cells is associated 
with increased expression of Bax protein and decreased 





treatment of HepG2 cells causes loss of mitochondrial 
membrane potential (m), releases of Cyt C from the 
mitochondrial intermembrane space toward the cytosol, 
and proteolytic activation of caspases 9 and 3. 
 
 
MATERIALS AND METHODS   
 
Chemicals and reagents 
 
NCTD of analytical grade purity was obtained from Sigma Chemical 
Co. ( St Louis, USA); a stock solution (5 mg/ml) in RPMI1640 
(HyClone, USA) was prepared and stored in the dark at 4°C. Final 
concentrations of NCTD used for different experiments were 
prepared by diluting the stock with RPMI-1640. D-Hanks’ solution, 
penicillin, streptomycin, fetal bovine serum and EDTA, 
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), 
propidium iodide in this study were purchased from Sigma Chemical 
Co. (St Louis, USA). Anti-rabbit Bcl-2, Bax, cyt C and  -actin 
antibodies and HRP-conjugated goat anti-rabbit Ig were from R and 
D Systems Inc (Minneapolis ,UCA). Caspase 3 and caspase 9 were 
obtained from Beyotime Institute of Biotechnology (Nantong, China). 
JC-1 kit were purchased from keygen Biotechnology Co., LTD 
(Nanjing, China). Annexin V-FITC kit was obtained from Beijing 
Biosea Biotechnology Co., LTD (Beijing, China). 
 
 
Cell line and cell culture 
 
The human hepatoma cell line, HepG2 was obtained from the 
department of oncology, Zhongnan Hospital of Wuhan University 
(Wuhan, China). The cells were cultured in RPMI-1640 medium 
(HyClone, USA) supplemented with 10% heat-inactivated fetal 
bovine serum (HyClone, USA), 100 U/ml penicillin and 100 g/ml 
streptomycin. Cultures were maintained in a humidified atmosphere 
of 5% CO2 at 37°C. 
 
 
Cell growth inhibition studies  
 
The effect of NCTD on cell proliferation was measured by MTT 
assay (Liu et al., 2010). In vitro growth inhibition effect of NCTD on 
HepG2 cells was determined by measuring MTT (3-(4, 
5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) dye 
absorbance of living cells. Briefly, cells (2×104 cells per well) were 
seeded in 96-well plates. After exposure to NCTD (2.5, 5, 10, 20 and 
40 g/ml ) for 24, 36 and 48 h, 20 l MTT solution (5 mg/ml in 
phosphate buffered saline (PBS)) was added to each well and the 
plates were incubated for an additional 4h at 37°C. The MTT 
solution in medium was aspirated off. To achieve solubilisation of 
the formazan crystal formed in viable cells, 200 l DMSO was added 
to each well. The absorbance rate of each well optical density (OD 
value) was measured at 570 nm by a spectrophotometer. The cell 
proliferation inhibition rate was calculated as 1-(average OD value of 




Annexin V/PI staining assay 
 
The extent of apoptosis was evaluated by annexin V-FITC and flow 
cytometry (Bai et al., 2010; Xu et al., 2010). Briefly, 1×106 cells/ml 
cells grown to about 60% confluence were treated with 10, 20 or 40 
g/ml of NCTD for 24 h. For annexin V/PI binding assay, cells were 
collected and washed with serum-containing media. Cells collected 
were washed with serum-containing media before being 
resuspended in 500 l of 1×binding buffer, followed by the addition 




of  5 l  of annexin V-FITC and 10 l of PI to cell suspension. Cells  
used as controls (0 l NCTD) were incubated with the vehicle 
(RPMI1640) alone. The mixture was then, incubated for 15 min at 
room temperature in the dark and immediately analyzed with the 
flow cytometer and cell quest software analysis. 
 
 
Measurement of mitochondrial membrane potential (m) 
 
m was measured with the lipophilic cation JC-1 probes, which is 
able to selectively enter mitochondria. JC-1 exists in a monomeric 
form emitting at 525 nm after excitation at 490 nm. Depending on 
m, JC-1 is able to form J-aggregates that are associated with a 
large shift in emission (575 nm). A shift in fluorescence from red 
(JC-1 aggregates, FL2) to green (JC-1 monomers, FL1) is detected 
as a reduction of 
, which implies JC-1 dissociation from mitochondria into the 
cytosol. Briefly, (Cossarizza et al., 2010), cells (1×106 cells/ml) in 10 
cm culture dishes were treated without or with NCTD (10, 20 and 40 
g/ml) for 24 h. Cells were trypsinized, washed in ice-cold PBS and 
incubated with 10 mM JC-1 at 37°C for 20 min in darkness. 
Subsequently, cells were washed twice with PBS and analyzed by 
flow cytometry. Excitation wave was set at 490 nm and the emitted 
green fluorescence of annexin V-FITC (FL1) and red fluorescence of 




Detection of cyt C release from the mitochondria to the cytosol 
 
Cyt C determination in cytosolic and mitochondrial fractions was 
done by western blotting. The cells were harvested after the 
respective treatments and washed once with ice-cold PBS. For 
isolation of mitochondria and cytosol, the cells were sonicated in 
buffer containing 10mM Tris-HCl pH 7.5, 10 mM NaCl, 175 mM 
sucrose and 12.5 mM EDTA and the cell extract centrifuged at 1000 
g for 10 min to pellet nuclei. The supernatant thus, obtained was 
centrifuged at 18000 g for 30 min to pellet the mitochondria and 
purified as previously described. The resulting supernatant was 
termed the cytosolic fraction. The pellet was lysed and protein 
content estimated in both fractions by Bradford’s method. Equal 
amounts of protein were separated on 15% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) then were 
electrotransferred to PVDF membrane. The membrane was then 
incubated in 5% non-fat milk in TBST (TBS: Tris-buffered-saline, 10 
mM Tris, 150 mM NaCl, pH 7.6 with 0.1% Tween 20) for 2 h followed 
by overnight incubation with the primary antibody separately. The 
incubated membranes were extensively washed with TBST before 
incubation for 2 h with the secondary anti-body. After extensive 
washing with TBST, the immune complexes were detected by 
enhanced chemiluminescence detection kit. 
 
 
Western blot analysis 
 
HepG2 cells were treated with various concentrations of NCTD (10, 
20 and 40 g/ml) for 24 h. Both adherent and floating cells were 
collected. Then, cells were lysed in ice-cold RIPA buffer (20 mmol/l 
Tris pH 7.5, 150 mmol/l NaCl, 1% NP40, 0.5% sodium  
deoxycholate, 1 mmol/l EDTA and 0.1%SDS) by pipetting up and 
down. Thereafter, cell lysates were placed on ice for 30 min and 
cleared by centrifugation at 12 000×g for 20 min at 4°C. The 
supernatants were collected. The protein concentration was 
determined by the bradford protein assay kit. Equivalent amounts of 
protein lysates were separated by electrophoresis in 12% SDS 
polyacrylamide gel and blotted onto nitrocellulose membrane 
(Amersham Biosciences, UK). Membranes were blocked with 5% 
non-fat dry milk in Tris-buffered  saline  containing  0.05% Tween  











































20(TBS-T)  and then probed with the primary antibody. The primary 
antibodies were diluted in 1% nonfat dry milk in TBS-T as indicated 
and used for immunoblotting. Protein expression was detected 
using a primary polyclonal antibody against Bax, Bcl-2, -actin and a 
secondary polyclonal antibody conjugated with peroxidase. After 
washing in TBS-T, membranes were incubated with their appropriate 
horseradish peroxidase-conjugated secondary antibodies and 
developed using an enhanced chemiluminescence detection system 
according to the instructions of the manufacturer and were exposed 
to x-ray film. 
 
 
Caspase activity assay 
 
Analysis of caspase-3 and caspase-9 activities was performed using 
caspase apoptosis detection kit according to the manufacturer’s 
instruction. In brief, cells (1×106) were pelleted by centrifugation, 
washed with PBS two times and incubated in 500 l lysis buffer on 
ice for 10 min, then 1×reaction buffer and 10 l caspase-3 
(DEVD-AFC), caspase-9 (IEVD-AFC) substrates was added to lysis 
buffer. The reaction mixtures were incubated at 37°C for 60 min. 





The data were expressed as mean ± standard deviation (SD) and 
analyzed by the SPSS 13.0 software to evaluate the statistical 
difference. Statistical analysis was done using the ANOVA and 
Bonferroni test. Values between different treatment groups were 
compared. Results were considered significant at a P value of <0.05. 
All experiments were repeated thrice. 
RESULTS   
 
Proliferation inhibitory effect of NCTD 
 
To determine the inhibitory effects of NCTD on HepG2 
cells, cytotoxicity assays  were carried out as described 
earlier. Figure 1 shows the apoptotic curves of HepG2 
cells treated with various concentrations of NCTD for 
different exposure times. As shown in the figure, the 
inhibitory effect of NCTD at low concentrations (2.5 µg/ml) 
was not evident, with 8.01±0.44 at 24 h; as the con- 
centration increased, the growth of HepG2 cells was 
markedly inhibited in a dose-dependent manner, with 
59.09%±3.25 at 24 h (p < 0.05). These data indicate that, 
NCTD exerts a significant cytotoxic effect upon HepG2 
cells in a dose- and time-dependent manner. 
 
 
Flow cytometric estimation of NCTD induced 
apoptosis and necrosis 
 
We characterized NCTD-induced apoptosis by annexin 
V/PI dual staining. Apoptotic cells lose asymmetry of 
membrane phospholipid, which leaves phosphatidylserine 
(PS) on the outer leaflet of the plasma membrane. One of 
the tools for studying apoptosis is to quantify the PS 
externalization  by  binding  of  annexin  V.  PI  is a 
non-specific DNA intercalating agent, which is excluded by 











the plasma membrane of living cells and thus, can 
be used to distinguish necrotic cells from apoptotic 
and living cells by supravital staining without prior 
permeabilization. This assay divides apoptotic 
cells into two stages: early (annexin V+/PI-) and 
late apoptotic/necrotic (V+/PI+). As shown in Figure 
2, treatment with various concentrations of NCTD 
(10, 20 and 40 g/ml) for 24 h resulted in a 
concentration-dependent increase in both early 
and late apoptotic/necrotic cells. Furthermore, the 
percentage of early apoptotic cells was greater 
than that of late apoptotic/necrotic cells. 
 
 
Mitochondria membrane potential (m) 
determination 
 
There is general agreement that mitochondria are 
required  for  apoptosis. Change in mitochondria 
membrane potential (m) is one of the early 
events leading to functional alterations and 
compromise of integrity of mitochondria. To 
examine whether the m pathway is involved in 
NCTD-induced apoptosis, m detection was 
performed using dye JC-1, which was used to 
assess mitochondrial membrane depolarization. 
As shown in Figure 3, exposure to NCTD for 24 h 
resulted in a significant decrease in the ratio 
between red and green fluorescence by approxi- 
mately 34.1, 42.6 and 55.8% at 10, 20 and 40 
g/ml, respectively. This suggests that, treatment 
with various concentrations of NCTD (10, 20 and 
40 g/ml) for 24 h resulted in significant decreases 
of m. The results imply that, NCTD induces m 
dissipation in a concentration-dependent manner. 
 
 
Cyt C release from mitochondria to cytosol 
 
Cyt  C release from mitochondria is a critical step 
in the apoptotic cascade since this activates 
downstream caspases. To investigate the release 
of cyt C in NCTD-treated HepG2 cells, we con- 
ducted western blot in both the cytosolic and 
mitochondrial fractions. The results demonstrate a 
concentration-dependent increase in the cytosolic 
cyt C after treatment with NCTD. Simultaneously, 
there was a decrease in cyt C in the mitochondria 
fraction (Figure 4). 
 
 
Expression of Bax and Bcl-2 protein 
 
The collapse of the mitochondria membrane 
potential occurs through the formation of pores on 
the mitochondria by dimerized Bax or activated Bid, 
Bak or Bad proteins. Bax and Bcl-2 are proteins 
that belong to the Bcl-2 family and they serve as 
pro-and anti-apoptotic effectors, respectively, to 
govern mitochondria outer membrane permeabili- 
zation  (MOMP).  The  imbalance  of anti- and 
pro-apoptotic protein expression is one of the 
major mechanisms underlying the ultimate fate of  






Figure 3. NCTD-Induced m depolarization in HepG2 cells. Cells were treated without or with NCTD at the concentrations indicated. Change in m was determined by flow cytometric 











Table 1. Effects of NCTD on the activation of caspase-3, -9. 
 
Concentration Caspase 3 Caspase 9 
Control 10.07±1.13 36.32±4.39 
10 (g/ml) 18.76±1.22* 48.87±1.72* 
20 (g/ml) 35.71±2.83** 53.89±2.54** 
40 (g/ml) 37.32±1.28** 55.92±3.16** 
 




cells during the apoptotic process. The results show that, 
Bax protein levels increased in a dose-dependent manner 
in NCTD-treated cells, whereas Bcl-2 levels decreased 
slightly (Figure 4). 
 
 
NCTD activation of caspase 9 and caspase 3 
 
It is well-known that, proteins of the Bcl-2 family play a 
pivotal role in apoptosis by affecting caspase activation. 
Caspase-9, an aspartic-acid-specific protease, is an 
initiator caspase linked to the mitochondria death pathway 
and it is activated dearly in the apoptotic cascade by cyt C. 
Activated caspase-9 stimulates the proteolytic activity of 
other downstream caspases, including caspase-3. Acti- 
vated caspase-3, then, leads to the cleavage of numerous 
proteins. In this study, we demonstrated that, NCTD 
increased caspase 9 and caspase 3 activities in a 





Hepatoma is the leading cause of cancer-related death in 
the world. Treatment of this disease has largely been 
unsuccessful, mean survival after diagnosis being limited 
to a few months. Thus, there is an urgent need to identify 
new therapeutic agents for the treatment of hepatoma in 
vivo. Natural product extracts are a rich source of small 
molecules that display antitumor activity (Dholwani et al., 
2008). Cantharidin, the form of the dried body of the 
Chinese blister beetles, displays antitumor activity and 
induces apoptosis in many types of tumor cells (Huang et 
al., 2011; Kuo et al., 2010; Zhang et al., 2010). However, 
the highly toxicity for the gastrointestinal tract and kidney 
limits its usage. A series of bioactive analogues have been 
synthesized in an attempt to increase the utility and to 
reduce the toxicity of cantharidin. NCTD, the demethylated 
form of cantharidin, appeared to cause the least 
nephrotoxic and inflammatory side effects. The Chinese 
herb cantharidin has been used in traditional Chinese 
medicine for more than two thousand years. The first 
recorded use of cantharidin as an anti-cancer agent was 
in 1264 (Wang, 1989). Currently, multiple studies in vitro 
and in vivo have shown that, NCTD was cytotoxic to 
various types of tumor cells. The significant apoptotic 
effects was also observed in tumor cells treated by NCTD. 
However, the exact mechanism responsible for the apop- 




totic effect is not thoroughly elucidated. 
A large family of related protein products, which are able 
to balance mitogenesis and cell death stimuli, regulate 
apoptosis. This well-defined class of genes is the Bcl-2 
family. The Bcl-2 family consists of intracellular, 
membrane-associated proteins and there is evidence that 
they may act by controlling mitochondrial permeability 
(Xiao et al., 2009; Leibowitz et al., 2010). Bcl-2 can inhibit 
apoptosis caused by a variety of physiological and 
pathological stimuli. However, its exact mechanism of 
action is mostly unknown. Several proteins have an amino 
acid sequence homology with Bcl-2, but some of them 
function as promoters of cell death rather than suppres- 
sors of apoptosis. One of these is Bax, a protein with an 
extensive amino acid homology with Bcl-2 and it functions 
to counter the effects of Bcl-2 on cell survival. Moreover, 
Bax has been shown to bind the C-terminal domain of 
Bcl-2, forming heterodimers with it. It has been proposed 
that the ratio of Bcl-2 to Bax expression determines 
whether a cell is protected or sent to programmed cell 
death. The Bax gene is ubiquitously expressed and repre- 
sents a protective factor whose expression is activated by 
different stimuli such as drug. In addition, Bax is a well 
known upstream mediator of caspases-9-3, which sub- 
sequently, lead to DNA fragmentation and cell apoptosis. 
In this study, cells treated with NCTD increased the level 
of the pro-apoptotic protein Bax and decreased the level 
of the anti-apoptotic protein Bcl-2, suggesting that, NCTD 
induced apoptosis in HepG2 cells by modulating Bcl-2 
family proteins. 
Early cellular apoptosis is accompanied by disruption of 
the mitochondrial   membrane, resulting in a rapid collapse 
in the electrochemical gradient (Jeong et al., 2008). 
Previous studies have shown that, activation of the 
mitochondrial pathway by toxicants frequently results in 
the release of cyt C from the mitochondria into the cytosol. 
The significance of cyt C to the apoptotic process was 
revealed by the finding that, mitochondrially released cyt 
C combines with apoptosis protease activating factor-1, 
procaspase-9 and dATP in the cytosol, producing active 
caspase-9 (Oberst et al., 2008; Scorrano et al., 2009; 
Brooks et al., 2009). The activation of this initiator cas- 
pase then leads to the proteolytic activation of caspase-3, 
the primary effector caspase of the cell. In this study, a 
remarkable attenuation of m occurred in cells exposed 
to NCTD in a concentration-dependent manner, but not in 
the untreated cells. Moreover, a concentration-dependent 
decrease in the mitochondrial cyt C level with a concomitant 
increase in the corresponding cytosolic fraction, was 
clearly observed when cells were incubated with NCTD. 
In addition, in this study, we also observed that, NCTD 





In this study, our data  indicated  that  NCTD  induced  
apoptosis in HepG2 cells via mitochondrial pathway  and 




these findings may provide new insights for understanding 
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